SynergyMed

SynergyMed has developed a cure for cancer that takes just ten minutes to administer.

This non-surgical solution has destroyed cancerous tumors in mice and dogs, and did so without damaging surrounding healthy tissue, causing cosmetic deformities, or affecting the subject’s quality of life. Now the company has its sights set on destroying similar tumors in humans.

SynergyMed has signed Letters of Intent (LOIs) from Boston Scientific and Medtronic and projects to generate $500 million in revenue within the next five years.

It will continue to run clinical studies treating tumors in dogs, and aims to start generating sales of its veterinary device later this year.

Team Background

Anan Copty - Chief Executive Officer

Anan has more than twenty-five years of technical and leadership experience.

Prior to starting SynergyMed, he founded NIMD, a medical-device company aiming to treat cancer by combining microwave and metal-based nanoparticles — similar to SynergyMed’s mission. He started NIMD after spending a decade with Intel as a senior R&D physicist.

Earlier in his career, he was a staff scientist with Radiation Monitoring Devices, a company focused on radiation detection and imaging. Before that, he was an R&D physicist at Harvard Medical School, where he built and tested radio-frequency technology for Magnetic Resonance Imaging (MRI) applications. He began his career as a research assistant at Harvard’s Physics Department.

Anan earned a Bachelor’s degree in Physics from Gordon College, a Master’s degree in Physics from Boston College, and a Ph.D. in Physics from the Hebrew University of Jerusalem.

Daniel Kacher - Director of Clinical Studies

In addition to his role with SynergyMed, Dan has spent the past twenty-eight years at Brigham and Women’s Hospital in Boston.

He spent the first fourteen years as a senior project manager in the hospital’s radiology department, and has served as a senior-clinical engineer since 2011. His main task in this role is to support clinical efforts for an advanced multi-modality image guided operating suite (AMIGO), which involves an MRI scanner that travels to the patient.

Prior to starting at this hospital, Dan was a fellow at Harvard Medical School. He earned a Bachelor’s degree in Biomedical Engineering from Rensselaer Polytechnic Institute, a Master’s in Biomedical Engineering from Boston University, and a Ph.D. in Electrical Engineering from Northeastern University.

Yahya Dajani - VP of Business Development

Yahya began his career at ADNOC Group, one of the world’s leading energy producers based in Abu Dhabi. He worked as a performance and contracts analyst and a corporate planning advisor.

From there, he was a managing director for a consulting business, then became Vice President of Sales with NCA Scientific Monitoring, part of National Compliance Australia, a company dedicated to bringing scientific education to hospitals around the world.

He earned a Bachelor’s degree in Entrepreneurship from the University of Oregon.

Co-Investors